Original Research

Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults

Ngo LY, Haeberle A, Dyck-Jones J, Gelmont D, Yel L

Open Access Journal of Clinical Trials 2014, 6:55-61

Published Date: 23 June 2014